Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms
- PMID: 33399840
- PMCID: PMC7786241
- DOI: 10.1001/jama.2020.23567
Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms
Abstract
Importance: The prevalence of pulmonary embolism in patients with chronic obstructive pulmonary disease (COPD) and acutely worsening respiratory symptoms remains uncertain.
Objective: To determine the prevalence of pulmonary embolism in patients with COPD admitted to the hospital for acutely worsening respiratory symptoms.
Design, setting, and participants: Multicenter cross-sectional study with prospective follow-up conducted in 7 French hospitals. A predefined pulmonary embolism diagnostic algorithm based on Geneva score, D-dimer levels, and spiral computed tomographic pulmonary angiography plus leg compression ultrasound was applied within 48 hours of admission; all patients had 3-month follow-up. Patients were recruited from January 2014 to May 2017 and the final date of follow-up was August 22, 2017.
Exposures: Acutely worsening respiratory symptoms in patients with COPD.
Main outcomes and measures: The primary outcome was pulmonary embolism diagnosed within 48 hours of admission. Key secondary outcome was pulmonary embolism during a 3-month follow-up among patients deemed not to have venous thromboembolism at admission and who did not receive anticoagulant treatment. Other outcomes were venous thromboembolism (pulmonary embolism and/or deep vein thrombosis) at admission and during follow-up, and 3-month mortality, whether venous thromboembolism was clinically suspected or not.
Results: Among 740 included patients (mean age, 68.2 years [SD, 10.9 years]; 274 women [37.0%]), pulmonary embolism was confirmed within 48 hours of admission in 44 patients (5.9%; 95% CI, 4.5%-7.9%). Among the 670 patients deemed not to have venous thromboembolism at admission and who did not receive anticoagulation, pulmonary embolism occurred in 5 patients (0.7%; 95% CI, 0.3%-1.7%) during follow-up, including 3 deaths related to pulmonary embolism. The overall 3-month mortality rate was 6.8% (50 of 740; 95% CI, 5.2%-8.8%). The proportion of patients who died during follow-up was higher among those with venous thromboembolism at admission than the proportion of those without it at admission (14 [25.9%] of 54 patients vs 36 [5.2%] of 686; risk difference, 20.7%, 95% CI, 10.7%-33.8%; P < .001). The prevalence of venous thromboembolism was 11.7% (95% CI, 8.6%-15.9%) among patients in whom pulmonary embolism was suspected (n = 299) and was 4.3% (95% CI, 2.8%-6.6%) among those in whom pulmonary embolism was not suspected (n = 441).
Conclusions and relevance: Among patients with chronic obstructive pulmonary disease admitted to the hospital with an acute worsening of respiratory symptoms, pulmonary embolism was detected in 5.9% of patients using a predefined diagnostic algorithm. Further research is needed to understand the possible role of systematic screening for pulmonary embolism in this patient population.
Conflict of interest statement
Figures
Comment in
-
Pulmonary Embolism Prevalence Among Hospitalized Patients With COPD.JAMA. 2021 May 11;325(18):1902-1903. doi: 10.1001/jama.2021.3244. JAMA. 2021. PMID: 33974025 No abstract available.
-
Pulmonary Embolism Prevalence Among Hospitalized Patients With COPD.JAMA. 2021 May 11;325(18):1901-1902. doi: 10.1001/jama.2021.3241. JAMA. 2021. PMID: 33974026 No abstract available.
Similar articles
-
Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial.JAMA. 2021 Oct 5;326(13):1277-1285. doi: 10.1001/jama.2021.14846. JAMA. 2021. PMID: 34609451 Free PMC article. Clinical Trial.
-
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial.Thromb Res. 2023 Nov;231:58-64. doi: 10.1016/j.thromres.2023.09.013. Epub 2023 Sep 28. Thromb Res. 2023. PMID: 37806116
-
[The COPD-PE study: prevalence and prediction of pulmonary embolism in acute exacerbations of chronic obstructive pulmonary disease].Rev Mal Respir. 2004 Sep;21(4 Pt 1):791-6. doi: 10.1016/s0761-8425(04)71420-5. Rev Mal Respir. 2004. PMID: 15536380 French.
-
Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis.Chest. 2009 Mar;135(3):786-793. doi: 10.1378/chest.08-1516. Epub 2008 Sep 23. Chest. 2009. PMID: 18812453 Review.
-
Pulmonary Embolism and Chronic Obstructive Pulmonary Disease.Semin Thromb Hemost. 2023 Nov;49(8):809-815. doi: 10.1055/s-0042-1756190. Epub 2022 Sep 15. Semin Thromb Hemost. 2023. PMID: 36108648 Review.
Cited by
-
Is There a Correlation Between the Location of the Clot in the Pulmonary Arterial Tree with the Location of the Mucus Plug in the Pulmonary Bronchial Tree in Patients with chronic obstructive pulmonary disease Experiencing Pulmonary Embolism? Novel Findings.Thorac Res Pract. 2024 Nov 1;25(6):203-208. doi: 10.5152/ThoracResPract.2024.23137. Thorac Res Pract. 2024. PMID: 39511818 Free PMC article.
-
Biomarkers of Prothrombotic State and Risk Assessment of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis. 2024 Oct 11;19:2273-2283. doi: 10.2147/COPD.S466563. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39416877 Free PMC article.
-
Tenecteplase Catheter-Directed Thrombolytic Therapy in Submassive Pulmonary Embolism: A Case Report.Case Rep Crit Care. 2024 Aug 21;2024:3839630. doi: 10.1155/2024/3839630. eCollection 2024. Case Rep Crit Care. 2024. PMID: 39206426 Free PMC article.
-
Early detection and prediction of acute exacerbation of chronic obstructive pulmonary disease.Chin Med J Pulm Crit Care Med. 2023 Jun 2;1(2):102-107. doi: 10.1016/j.pccm.2023.04.004. eCollection 2023 Jun. Chin Med J Pulm Crit Care Med. 2023. PMID: 39170822 Free PMC article. Review.
-
Impact of connective tissue diseases on inpatient outcomes in gastrointestinal bleeding: insights from a national database analysis.Transl Gastroenterol Hepatol. 2024 Jun 25;9:35. doi: 10.21037/tgh-24-5. eCollection 2024. Transl Gastroenterol Hepatol. 2024. PMID: 39091649 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
